BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2158159)

  • 1. Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients.
    Gratama JW; Oosterveer MA; Lepoutre JM; van Rood JJ; Zwaan FE; Vossen JM; Kapsenberg JG; Richel D; Klein G; Ernberg I
    Transplantation; 1990 Apr; 49(4):725-30. PubMed ID: 2158159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of multiple Epstein-Barr viral strains in allogeneic bone marrow transplant recipients.
    Gratama JW; Lennette ET; Lönnqvist B; Oosterveer MA; Klein G; Ringdén O; Ernberg I
    J Med Virol; 1992 May; 37(1):39-47. PubMed ID: 1320097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation.
    Styczynski J; Tridello G; Gil L; Ljungman P; Hoek J; Iacobelli S; Ward KN; Cordonnier C; Einsele H; Socie G; Milpied N; Veelken H; Chevallier P; Yakoub-Agha I; Maertens J; Blaise D; Cornelissen J; Michallet M; Daguindau E; Petersen E; Passweg J; Greinix H; Duarte RF; Kröger N; Dreger P; Mohty M; Nagler A; Cesaro S
    J Clin Oncol; 2016 Jul; 34(19):2212-20. PubMed ID: 27091716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency.
    Gratama JW; Oosterveer MA; Zwaan FE; Lepoutre J; Klein G; Ernberg I
    Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8693-6. PubMed ID: 2847171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus infection following bone-marrow transplantation.
    Sullivan JL; Wallen WC; Johnson FL
    Int J Cancer; 1978 Aug; 22(2):132-5. PubMed ID: 29839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation.
    Lucas KG; Small TN; Heller G; Dupont B; O'Reilly RJ
    Blood; 1996 Mar; 87(6):2594-603. PubMed ID: 8630428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of Epstein-Barr virus status and post-transplant lymphoproliferative disease in pediatric thoracic transplantation.
    Harwood JS; Gould FK; McMaster A; Hamilton JR; Corris PA; Hasan A; Gennery AR; Dark JH
    Pediatr Transplant; 1999 May; 3(2):100-3. PubMed ID: 10389130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.
    Gustafsson A; Levitsky V; Zou JZ; Frisan T; Dalianis T; Ljungman P; Ringden O; Winiarski J; Ernberg I; Masucci MG
    Blood; 2000 Feb; 95(3):807-14. PubMed ID: 10648390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human herpesvirus 8 DNA in serum during seroconversion in allogeneic bone marrow transplant recipients.
    Gentile G; Capobianchi A; Volpi A; Palù G; Pica F; Calistri A; Biasolo MA; Martino P
    J Natl Cancer Inst; 2005 Jul; 97(13):1008-11. PubMed ID: 15998954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
    Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
    Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.
    Shapiro NL; Tang CG; Bhattacharyya N
    Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus infection in allogeneic marrow grafting: lessons for transplant physicians and virologists.
    Gratama JW; Oosterveer MA; Lepoutre J; Fibbe WE; Ringdén O; Vossen JM; Willemze R; Bolhuis RL; van Rood JJ; Ernberg I
    Ann Hematol; 1992 Jun; 64 Suppl():A162-5. PubMed ID: 1322190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-related serology in marrow transplant recipients.
    Lange B; Henle W; Meyers JD; Yang LC; August C; Koch P; Arbeter A; Henle G
    Int J Cancer; 1980 Aug; 26(2):151-7. PubMed ID: 6259066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus in pediatric patients after renal transplantation.
    Schwab M; Böswald M; Korn K; Ruder H
    Clin Nephrol; 2000 Feb; 53(2):132-9. PubMed ID: 10711415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo generation of effective Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocytes from the peripheral blood of immunocompetent Epstein Barr virus-seronegative individuals.
    Metes D; Storkus W; Zeevi A; Patterson K; Logar A; Rowe D; Nalesnik MA; Fung JJ; Rao AS
    Transplantation; 2000 Nov; 70(10):1507-15. PubMed ID: 11118098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease.
    Verschuuren E; van der Bij W; de Boer W; Timens W; Middeldorp J; The TH
    J Med Virol; 2003 Feb; 69(2):258-66. PubMed ID: 12683416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal B-cell lymphoproliferative syndrome in allogeneic marrow graft recipients. A clinical, immunobiological and pathological study.
    Simon M; Bartram CR; Friedrich W; Arnold R; Schmeiser T; Hampl W; Müller-Hermelink HK; Heymer B
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(5):307-19. PubMed ID: 1685038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG anti-tetanus toxoid antibody production induced by Epstein-Barr virus from B cells of human marrow transplant recipients.
    Jin NR; Lum LG
    Cell Immunol; 1986 Aug; 101(1):266-73. PubMed ID: 2427210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus infection after kidney transplantation.
    Kaden J; Petersen S; Kaden K; May G
    Transpl Int; 1998; 11 Suppl 1():S119-24. PubMed ID: 9664960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.